Streetbeat News

Earnings

CRGY

Crescent Energy (NYSE:CRGY) reported Q4 2023 earnings of $0.610 per share, surpassing the $0.170 estimate by 258.82%, and sales of $657.728M, exceeding the $607.017M estimate by 8.35%. However, this represents a 3.95% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:25 pm

DSP

Viant Technology (NASDAQ:DSP) reported Q4 earnings with an EPS of $0.14, surpassing the estimated -$0.03 by 567%. Revenue increased by $9.90 million from the previous year. The company has a history of beating EPS estimates, leading to a share price increase of 12% the day after last quarter's earnings were announced.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 9:25 pm

NKTR

Nektar Therapeutics (NASDAQ:NKTR) reported Q4 2023 earnings with a GAAP EPS of $(0.22), surpassing the $(0.23) estimate. Sales reached $23.89M, exceeding the $18.05M forecast, marking an 8.45% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:24 pm

DSP

Viant Technology (NASDAQ:DSP) reported Q4 2023 adjusted EPS of $0.14, surpassing the $(0.03) estimate, but its sales of $64.41M fell short of the $65.92M estimate, marking an 18.16% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:21 pm

ATXS

Astria Therapeutics (NASDAQ:ATXS) reported a Q4 EPS loss of $(0.86), marking a 19.44% increase in losses compared to $(0.72) per share from the same period last year.

Portfolio Pulse from Happy Mohamed

March 04, 2024 | 9:20 pm

EOSE

Eos Energy Enterprises projects its FY24 revenue to be between $60M-$90M, significantly lower than the estimated $130.533M.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:19 pm

AVAV

AeroVironment's stock price increased following the announcement of their Q3 financial results, which exceeded expectations, and the company also provided positive guidance for the future.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:18 pm

VATE

Innovate (NYSE:VATE) reported a decrease in Q4 EPS to $(0.12) from $(0.09) YoY and a sales decline to $361.00M from $409.30M YoY, indicating a 33.33% decrease in EPS and an 11.80% decrease in sales.

Portfolio Pulse from Happy Mohamed

March 04, 2024 | 9:18 pm

GTLB

GitLab shares are trading lower following the company's announcement of Q1 and FY25 EPS guidance that fell below analyst estimates.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:17 pm

AKYA

Akoya Biosciences (NASDAQ:AKYA) reported Q4 earnings with an EPS of $-0.22, beating estimates by 19.0% and showing a revenue increase of $5.27 million from the previous year. The company has a history of surpassing EPS estimates, leading to a share price increase.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 9:15 pm